Income statement
CAD
Annual
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 37M | 25M | 29M | 24M | 24M |
| Gross Profit | 10M | 7M | 9M | 6M | 7M |
| Operating Income | 4M | 3M | 3M | 2M | 3M |
| EBITDA | 5M | 3M | 3M | 3M | 3M |
| Net Income | 3M | 2M | 2M | 1M | 2M |
| EPS (Diluted) | — | — | — | — | — |
Industrials
Live Price
Offline$2.17
+0.00% today
1Y Change
+38.22%
Window
Jun 27, 2025 → Jun 25, 2026
Coverage: 249 bars · Jun 27, 2025 → Jun 25, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
BioRem Inc. (BIRMF) is a Industrials stock with a market cap of $50.00M. The stock last traded around $2.17 and up 38.2% across the available one-year price window (Jun 27, 2025 → Jun 25, 2026). Baseline metrics include revenue growth of +13.1%, EPS growth of +57.9%, a dividend yield of 0.0%. What stands out right now is revenue +13.1%, EPS +57.9%, free cash flow +119.3% with operating margin 15.6% and ROIC 28.3%. Valuation is more restrained than many high-expectation growth names at P/E 11.4 and price/sales 1.3. Stock Foundry combines BIRMF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Industrials peers on this page.
Benchmark Edge
Normalized return, excess return, max drawdown, and calendar-year wins against the benchmarks investors actually use.
BIRMF
—
Normalized return
SPY
--
S&P 500
Excess Return
--
Relative to SPY
BIRMF Max Drawdown
-24.72%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for BIRMF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$24.4M
-0.4% YoY
FY Net Income
$2.1M
+61.0% YoY
Free Cash Flow
$3.0M
-19.0% YoY
Revenue Growth
+13.1%
EPS Growth
+57.9%
Gross Margin
30.1%
Net Margin
11.4%
Income statement
CAD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 37M | 25M | 29M | 24M | 24M |
| Gross Profit | 10M | 7M | 9M | 6M | 7M |
| Operating Income | 4M | 3M | 3M | 2M | 3M |
| EBITDA | 5M | 3M | 3M | 3M | 3M |
| Net Income | 3M | 2M | 2M | 1M | 2M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
CAD
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Cash & Equivalents | 5M | 2M | 4M | 4M | 9M |
| Total Assets | 29M | 24M | 21M | 19M | 22M |
| Total Liabilities | 18M | 17M | 16M | 17M | 8M |
| Shareholder Equity | 11M | 7M | 5M | 2M | 14M |
| Total Debt | 4M | 4M | 5M | 6M | 828K |
| Net Debt | -2M | 2M | 971K | 1M | -8M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
3M
-11.6% YoY
Capital Expenditures
342K
-350.7% YoY
Free Cash Flow
3M
-19.0% YoY
Key ratios
Gross Margin
30.1%
Operating Margin
15.6%
Net Margin
11.4%
ROE
39.5%
Debt / Equity
0.19x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.